Emory Genetics Lab Launches Sequencing-Based Genetic Testing for Three Congenital Disorders
May 25, 2010
Emory Genetics Lab Launches Sequencing-Based Genetic Testing for Three Congenital Disorders
The sequencing will be done on ABI's SOLiD, and over the next three months Emory plans to add sequencing-based testing for mitochondrial diseases, prostate cancer, hearing loss, cardiomyopathy, and various types of mental retardation.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Emory to Convert Dx Gene Panels from SOLiD to Ion Torrent; Plans to Launch Clinical Exome on HiSeq
March 21, 2012 / Clinical Sequencing News - Sequencing Breaks into the Clinic in 2011, but Ethical, Regulatory, and Technical Hurdles Remain
January 4, 2012 / Clinical Sequencing News - Next-Gen Sequencing Makes Inroads into Clinical Applications in 2010
January 4, 2011 / In Sequence - NCGR, Aiming to Diversify Platforms, Acquires Five SOLiD 4 Instruments
September 7, 2010 / In Sequence - Mayo Clinic Assesses Target-Capture Options as Step Toward Sequencing-Based Molecular Diagnostics
July 13, 2010 / In Sequence